Latest News
-
April 3, 2026 | News
With A Clear Focus And Promising Asset, Crystalys Is Skipping Phase 2 Trials For Gout
-
March 30, 2026 | News
Changing Faces: Board of Directors and Advisory Boards, February 2026
-
February 18, 2026 | News
NewCo boom shows no signs of slowing
-
February 2, 2026 | Press Releases
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites